Short answer
FENNEC PHARMACEUTICALS INC. (FENC) filed an 8-K current report with the SEC on April 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Rostislav Raykov retiring from Fennec’s Board after the 2026 annual meeting.
FENNEC PHARMACEUTICALS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Rostislav Raykov retiring from Fennec’s Board after the 2026 annual meeting
- Departure unrelated to disagreements over operations, policies or practices
- Board size reduction from six directors to five following the meeting
- No expected Board vacancies after Raykov’s departure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FENNEC PHARMACEUTICALS INC. 8-K filings
Get the next FENC 8-K as it lands
Follow FENC for push alerts, or ask the research agent what this filing means.